Esophagus and Gastric Cancer: Contemporary Treatment Approaches-AM2018
This session reviews current evidence based guidelines as well as the basis for guidelines pertaining to the treatment of esophageal and gastric cancer. Worldwide changes in epidemiology will be discussed. Current treatment strategies will be reviewed and compared. Contemporary techniques for use of radiation for esophageal and gastric cancer will be reviewed. Pertinent recent and ongoing clinical research will be highlighted.
This activity is available from January 3, 2019 through 11:59 p.m. Eastern time on January 2, 2021.
This activity was originally recorded at ASTRO’s 2018 Annual Meeting, October 22-24, 2018 in San Antonio, TX.
The meeting is designed to meet the interests of medical oncologists, radiation oncologists and surgeons.
- Discuss current treatment strategies of esophageal cancer: adjuvant and neoadjuvant treatment and surgery, definitive chemoradiation.
- Summarize the future of treatment: newer randomized trials, alternative treatment strategies and integration of novel agents with radiation therapy.
- Michael G. Haddock, MD is employed by the Mayo Clinic and holds a leadership position at ISIORT.
- Jennifer Wo, MD is employed by the Massachusetts General Hospital and has no disclosures to declare.
Additionally, the SA-CME Task Force and CME/MOC Committee had control over the content of this activity.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
- 1.50 Certificate of AttendanceThis activity was designated for 1.50 AMA PRA Category 1 Credit™.
- 1.50 SA-CME
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.
The American Society for Radiation Oncology (ASTRO) designates this Enduring material for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.50 self-assessment credits.
- No refunds, extensions or substitutions will be made for those registrants who, for any reason, were unable to attend or were tardy for the session.
- No credits will be granted and no refunds, exchanges or transfers will be given to those who do not pass.
- ASTRO staff cannot make modifications to your submitted materials.
One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.